Jazz Pharmaceuticals, Inc.
JAZZ Real Time Price USDRecent trades of JAZZ by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by JAZZ's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
JAZZ Revenue by Segment or Geography
New patents grants
-
Patent Title: Devices and methods for facilitating and controlling use of a medication Dec. 10, 2024
-
Patent Title: Sensitive drug distribution systems and methods Sep. 27, 2022
-
Patent Title: Sensitive drug distribution systems and methods Aug. 09, 2022
-
Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Dec. 28, 2021
-
Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Aug. 17, 2021
-
Patent Title: Devices and methods for facilitating and controlling use of a medication Jun. 15, 2021
-
Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Apr. 27, 2021
-
Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Apr. 06, 2021
-
Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Mar. 30, 2021
-
Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Oct. 27, 2020
-
Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Sep. 01, 2020
-
Patent Title: Devices and methods for facilitating and controlling use of a medication Oct. 31, 2017
-
Patent Title: Immediate release formulations and dosage forms of gamma-hydroxybutyrate Oct. 24, 2017
-
Patent Title: Method for administering ω-conopeptide Jul. 18, 2017
-
Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Jan. 10, 2017
-
Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Feb. 10, 2015
-
Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Oct. 14, 2014
-
Patent Title: Immediate release formulations and dosage forms of gamma-hydroxybutyrate Jul. 15, 2014
-
Patent Title: Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Jul. 08, 2014
-
Patent Title: Immediate release dosage forms of sodium oxybate Jul. 08, 2014
-
Patent Title: Method for administering omega-conopeptide Jul. 01, 2014
-
Patent Title: Sensitive drug distribution system and method May. 20, 2014
-
Patent Title: Pharmaceutical compositions of clonazepam and method of use thereof May. 06, 2014
-
Patent Title: Method for administering omega-conopeptide Feb. 18, 2014
-
Patent Title: Pharmaceutical compositions of benzodiazepines and method of use thereof Dec. 17, 2013
-
Patent Title: Sensitive drug distribution system and method Nov. 19, 2013
-
Patent Title: Pharmaceutical formulation for reducing pain Aug. 20, 2013
-
Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Jun. 11, 2013
-
Patent Title: Sensitive drug distribution system and method Jun. 04, 2013
-
Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Dec. 04, 2012
-
Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Sep. 11, 2012
-
Patent Title: Sensitive drug distribution system and method Feb. 22, 2011
-
Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Dec. 14, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to JAZZ
Recent picks made for JAZZ stock on CNBC
ETFs with the largest estimated holdings in JAZZ
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $JAZZ stock a Buy, Sell, or Hold?
- What is the price target for $JAZZ stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $JAZZ stock?
- Who owns the most shares of $JAZZ stock?
- What funds own $JAZZ stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view JAZZ Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.